Global Recombinant Human Granulocyte Colony-Stimulating Market Insights, Forecast to 2025

Global Recombinant Human Granulocyte Colony-Stimulating Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Recombinant Human Granulocyte Colony-Stimulating Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Type
1.4.2 Lenograstim (Granocyte)
1.4.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Application
1.5.2 Chemotherapy Induced Neutropenia
1.5.3 Before Blood Donation
1.5.4 Stem Cell Transplants
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size
2.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue 2014-2025
2.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales 2014-2025
2.2 Recombinant Human Granulocyte Colony-Stimulating Growth Rate by Regions
2.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Regions
2.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturers
3.1.1 Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturers
3.1.2 Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers
3.2 Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturers
3.2.1 Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturers (2014-2019)
3.2.2 Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers (2014-2019)
3.3 Recombinant Human Granulocyte Colony-Stimulating Price by Manufacturers
3.4 Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Human Granulocyte Colony-Stimulating Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Human Granulocyte Colony-Stimulating Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type
4.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type
4.3 Recombinant Human Granulocyte Colony-Stimulating Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Recombinant Human Granulocyte Colony-Stimulating Breakdown Data by Application
6 North America
6.1 North America Recombinant Human Granulocyte Colony-Stimulating by Country
6.1.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
6.1.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Recombinant Human Granulocyte Colony-Stimulating by Type
6.3 North America Recombinant Human Granulocyte Colony-Stimulating by Application
7 Europe
7.1 Europe Recombinant Human Granulocyte Colony-Stimulating by Country
7.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country
7.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Human Granulocyte Colony-Stimulating by Type
7.3 Europe Recombinant Human Granulocyte Colony-Stimulating by Application
8 Asia Pacific
8.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating by Region
8.1.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region
8.1.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating by Type
8.3 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating by Application
9 Central & South America
9.1 Central & South America Recombinant Human Granulocyte Colony-Stimulating by Country
9.1.1 Central & South America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
9.1.2 Central & South America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
9.1.3 Brazil
9.2 Central & South America Recombinant Human Granulocyte Colony-Stimulating by Type
9.3 Central & South America Recombinant Human Granulocyte Colony-Stimulating by Application
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating by Country
10.1.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country
10.1.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating by Type
10.3 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating by Application
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Company Business Overview
11.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.1.5 Amgen Recent Development
11.2 Qilu Pharmaceutical
11.2.1 Qilu Pharmaceutical Company Details
11.2.2 Company Business Overview
11.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.2.5 Qilu Pharmaceutical Recent Development
11.3 Shijiazhuang Pharmaceutical
11.3.1 Shijiazhuang Pharmaceutical Company Details
11.3.2 Company Business Overview
11.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.3.5 Shijiazhuang Pharmaceutical Recent Development
11.4 Kyowa Hakko Kirin
11.4.1 Kyowa Hakko Kirin Company Details
11.4.2 Company Business Overview
11.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.4.5 Kyowa Hakko Kirin Recent Development
11.5 Gensci
11.5.1 Gensci Company Details
11.5.2 Company Business Overview
11.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.5.5 Gensci Recent Development
11.6 Amoytop Biotech
11.6.1 Amoytop Biotech Company Details
11.6.2 Company Business Overview
11.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.6.5 Amoytop Biotech Recent Development
11.7 Hangzhou Jiuyuan
11.7.1 Hangzhou Jiuyuan Company Details
11.7.2 Company Business Overview
11.7.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.7.5 Hangzhou Jiuyuan Recent Development
11.8 Huaxin
11.8.1 Huaxin Company Details
11.8.2 Company Business Overview
11.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.8.5 Huaxin Recent Development
11.9 Triprime
11.9.1 Triprime Company Details
11.9.2 Company Business Overview
11.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.9.5 Triprime Recent Development
11.10 Sinovac
11.10.1 Sinovac Company Details
11.10.2 Company Business Overview
11.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.10.5 Sinovac Recent Development
11.11 Zhaoke
11.12 Kawin
12 Future Forecast
12.1 Recombinant Human Granulocyte Colony-Stimulating Market Forecast by Regions
12.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Regions 2019-2025
12.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Regions 2019-2025
12.2 Recombinant Human Granulocyte Colony-Stimulating Market Forecast by Type
12.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type 2019-2025
12.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Type 2019-2025
12.3 Recombinant Human Granulocyte Colony-Stimulating Market Forecast by Application
12.4 North America Recombinant Human Granulocyte Colony-Stimulating Forecast
12.5 Europe Recombinant Human Granulocyte Colony-Stimulating Forecast
12.6 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Forecast
12.7 Central & South America Recombinant Human Granulocyte Colony-Stimulating Forecast
12.8 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Human Granulocyte Colony-Stimulating Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Recombinant Human Granulocyte Colony-Stimulating Product Picture
Table Recombinant Human Granulocyte Colony-Stimulating Market Segments
Table Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Covered
Table Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Type 2019-2025 (KG) & (Million US$)
Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2018 & 2025
Figure Lenograstim (Granocyte) Product Picture
Table Major Manufacturers of Lenograstim (Granocyte)
Figure Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Product Picture
Table Major Manufacturers of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Application 2019-2025 (KG)
Figure Global Recombinant Human Granulocyte Colony-Stimulating 4900 Sales Market Share by Application in 2018
Figure Chemotherapy Induced Neutropenia
Figure Before Blood Donation
Figure Stem Cell Transplants
Figure Others
Figure Recombinant Human Granulocyte Colony-Stimulating Report Years Considered
Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size 2014-2025 (Million US$)
Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales 2014-2025 (KG)
Table Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Regions 2014-2019 (KG) & (Million US$)
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales by Regions 2014-2019 (KG)
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Regions 2014-2019
Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Regions 2014-2019
Figure 2018 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Regions
Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Regions 2014-2019 (Million US$)
Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Regions 2014-2019
Figure 2018 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Regions
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturers (2014-2019) (KG)
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturers (2014-2019)
Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturers (2014-2019) (Million USD)
Table Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers (2014-2019)
Figure Recombinant Human Granulocyte Colony-Stimulating Value Share by Manufacturers in 2018
Table Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Price (2014-2019) (USD/g)
Table Recombinant Human Granulocyte Colony-Stimulating Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Type
Table Date of International Manufacturers Enter into Recombinant Human Granulocyte Colony-Stimulating Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2014-2019) (KG)
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Type (2014-2019)
Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2014-2019)
Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2018
Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2014-2019) (Million US$)
Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Type (2014-2019)
Figure Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2014-2019)
Figure Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type in 2018
Table Recombinant Human Granulocyte Colony-Stimulating Price by Type 2014-2019 (USD/g)
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2014-2019) (KG)
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Application (2014-2019)
Figure Global Sales Recombinant Human Granulocyte Colony-Stimulating Market Share by Application (2014-2019)
Figure Global Sales Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2018
Figure North America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2014-2019 (KG)
Figure North America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2014-2019 (Million US$)
Table North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2014-2019) (KG)
Table North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2014-2019)
Figure 2018 North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country
Table North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2014-2019) (Million US$)
Table North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2014-2019)
Figure 2018 North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country
Figure United States Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure United States Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Canada Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Canada Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Mexico Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Table North America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2014-2019) (KG)
Table North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2014-2019)
Figure 2018 North America Recombinant Human Granulocyte Colony-Stimulating Market Share by Type
Table North America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2014-2019) (KG)
Table North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2014-2019)
Figure 2018 North America Recombinant Human Granulocyte Colony-Stimulating Market Share by Application
Figure Europe Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2014-2019 (KG)
Figure Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2014-2019) (KG)
Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2014-2019)
Figure 2018 Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country
Table Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2014-2019) (Million US$)
Table Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2014-2019)
Figure 2018 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country
Figure Germany Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Germany Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure France Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure France Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure UK Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Italy Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Russia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2014-2019) (KG)
Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2014-2019)
Figure 2018 Europe Recombinant Human Granulocyte Colony-Stimulating Market Share by Type
Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2014-2019) (KG)
Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2014-2019)
Figure 2018 Europe Recombinant Human Granulocyte Colony-Stimulating Market Share by Application
Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2014-2019 (KG)
Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2014-2019) (KG)
Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region
Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2014-2019) (Million US$)
Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country
Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure China Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Japan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure South Korea Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure South Korea Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure India Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure India Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Australia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Indonesia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Thailand Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Malaysia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Philippines Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Vietnam Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2014-2019) (KG)
Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2014-2019)
Figure 2018 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Share by Type
Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2014-2019) (KG)
Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2014-2019)
Figure 2018 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Share by Application
Figure Central & South America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2014-2019 (KG)
Figure Central & South America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2014-2019) (KG)
Table Central & South America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2014-2019)
Figure 2018 Central & South America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country
Table Central & South America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2014-2019) (Million US$)
Table Central & South America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2014-2019)
Figure 2018 Central & South America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country
Figure Brazil Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Brazil Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2014-2019) (KG)
Table Central & South America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2014-2019)
Figure 2018 Central & South America Recombinant Human Granulocyte Colony-Stimulating Market Share by Type
Table Central & South America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2014-2019) (KG)
Table Central & South America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2014-2019)
Figure 2018 Central & South America Recombinant Human Granulocyte Colony-Stimulating Market Share by Application
Figure Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2014-2019 (KG)
Figure Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2014-2019) (KG)
Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country
Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2014-2019) (Million US$)
Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country
Figure Turkey Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Turkey Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure GCC Countries Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure GCC Countries Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure Egypt Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2014-2019) (KG)
Figure South Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2014-2019) (KG)
Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2014-2019)
Figure 2018 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Share by Type
Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2014-2019) (KG)
Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2014-2019)
Figure 2018 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Share by Application
Table Amgen Company Details
Table Amgen Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table Qilu Pharmaceutical Company Details
Table Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Qilu Pharmaceutical Recent Development
Table Shijiazhuang Pharmaceutical Company Details
Table Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Shijiazhuang Pharmaceutical Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Kyowa Hakko Kirin Recent Development
Table Gensci Company Details
Table Gensci Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Gensci Recent Development
Table Amoytop Biotech Company Details
Table Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Amoytop Biotech Recent Development
Table Hangzhou Jiuyuan Company Details
Table Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Hangzhou Jiuyuan Recent Development
Table Huaxin Company Details
Table Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Huaxin Recent Development
Table Triprime Company Details
Table Triprime Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Triprime Recent Development
Table Sinovac Company Details
Table Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2014-2019)
Table Sinovac Recent Development
Table Zhaoke Company Details
Table Kawin Company Details
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Regions 2019-2025 (KG)
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Regions 2019-2025
Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Regions 2019-2025
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type 2019-2025 (KG)
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Type 2019-2025
Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Type 2019-2025 (Million US$)
Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Type 2019-2025
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application 2019-2025 (KG)
Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Application 2019-2025
Figure North America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2019-2025) (KG)
Figure North America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2019-2025) (KG)
Figure Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2019-2025) (KG)
Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2019-2025) (KG)
Figure Central & South America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2019-2025) (KG)
Figure Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Table Market Risks
Figure Porter's Five Forces Analysis
Table Recombinant Human Granulocyte Colony-Stimulating Value Chain
Table Recombinant Human Granulocyte Colony-Stimulating Customers List
Figure Channels of Distribution
Table Recombinant Human Granulocyte Colony-Stimulating Distributors List
Figure Distributors Pro

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs